Review
Published on 06 Aug 2024
Are we ready to integrate 3D culture systems in acute myeloid leukemia and bone marrow microenvironment research?
Frontiers in Hematology
doi 10.3389/frhem.2024.1407698
- 5,444 views
- 6 citations
178 Publications
volumes
Volume 3 - 2024
Community Case Study
Published on 25 Jul 2024
Effectiveness of biosimilar pegfilgrastim in patients with lymphoma after high-dose chemotherapy and autologous stem cell transplantation: a real-life study
Frontiers in Hematology
doi 10.3389/frhem.2024.1441070
- 1,513 views
Mini Review
Published on 22 Jul 2024
Targeting the bone marrow niche, moving towards leukemia eradication
Frontiers in Hematology
doi 10.3389/frhem.2024.1429916
- 3,551 views
- 1 citation
Original Research
Published on 15 Jul 2024
Real-world analysis of the underdiagnosis, clinical outcomes and associated burden of hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-TMA) in the United States
Frontiers in Hematology
doi 10.3389/frhem.2024.1405311
- 6,831 views
Review
Published on 12 Jul 2024
Clonal cytopenia of undetermined significance: definitions, risk and therapeutic targets
Frontiers in Hematology
doi 10.3389/frhem.2024.1419323
- 7,497 views
- 3 citations
Case Report
Published on 10 Jul 2024
Case report: Aggressive natural killer cell leukemia and refractory hemophagocytic lymphohistiocytosis in an adolescent
Frontiers in Hematology
doi 10.3389/frhem.2024.1413794
- 2,206 views
Review
Published on 08 Jul 2024
The sweet symphony of N-glycans in myeloid malignancies
Frontiers in Hematology
doi 10.3389/frhem.2024.1415618
- 2,009 views
- 1 citation
Mini Review
Published on 05 Jul 2024
Congenital dyserythropoietic anemia type II and ineffective erythropoiesis: challenges in diagnosis and management
Frontiers in Hematology
doi 10.3389/frhem.2024.1389820
- 4,570 views
- 1 citation
Original Research
Published on 20 Jun 2024
Effectiveness, safety, and tolerability of delayed dexamethasone, rituximab, and cyclophosphamide as first-line treatment in patients with Waldenström macroglobulinemia: data from the Sicilian Myeloma Network
Frontiers in Hematology
doi 10.3389/frhem.2024.1425677
- 1,848 views
Brief Research Report
Published on 17 Jun 2024
Novel cryopreservation medium for enhanced stability of T cells at −80°C
Frontiers in Hematology
doi 10.3389/frhem.2024.1346627
- 3,940 views
- 2 citations
Brief Research Report
Published on 13 Jun 2024
First clinical experience of isatuximab safety and tolerability in relapsed and refractory multiple myeloma: real-world data from a compassionate use program in Germany
Frontiers in Hematology
doi 10.3389/frhem.2024.1335161
- 1,788 views
- 1 citation
Mini Review
Published on 28 May 2024
Exploring extramedullary hematopoiesis: unraveling the hematopoietic microenvironments
Frontiers in Hematology
doi 10.3389/frhem.2024.1371823
- 9,848 views
- 5 citations
Original Research
Published on 10 May 2024
Crizanlizumab in adult patients with sickle cell disease: a retrospective German analysis
Frontiers in Hematology
doi 10.3389/frhem.2024.1374181
- 2,805 views
- 4 citations
Review
Published on 08 May 2024
AL amyloidosis: an overview on diagnosis, staging system, and treatment
Frontiers in Hematology
doi 10.3389/frhem.2024.1378451
- 9,247 views
- 2 citations
Brief Research Report
Published on 26 Apr 2024
Interference of daratumumab and efficacy of plerixafor on haematopoietic stem cell collection in Multiple Myeloma
Frontiers in Hematology
doi 10.3389/frhem.2024.1386973
- 1,981 views
- 2 citations
Original Research
Published on 18 Apr 2024
Morphological, clinical, and molecular profiling of post-polycythemia vera accelerated/blast phase occurring with and without antecedent secondary myelofibrosis
Frontiers in Hematology
doi 10.3389/frhem.2024.1356561
- 3,356 views
Brief Research Report
Published on 09 Apr 2024
Evaluating the effectiveness of COVID-19 vaccines in adults with sickle cell disease during the Omicron period of COVID-19 pandemic
Frontiers in Hematology
doi 10.3389/frhem.2024.1365268
- 1,541 views
Brief Research Report
Published on 04 Apr 2024
Constructing a novel clinical indicator model to predict the occurrence of thalassemia in pregnancy through machine learning algorithm
Frontiers in Hematology
doi 10.3389/frhem.2024.1341225
- 2,557 views
- 3 citations
Clinical Trial
Published on 28 Mar 2024
Phase II single-arm study of a combination of obinutuzumab and venetoclax in early relapsed or refractory diffuse large B-cell lymphoma—final results of the AGMT NHL15B study
Frontiers in Hematology
doi 10.3389/frhem.2024.1331008
- 1,709 views
Review
Published on 28 Mar 2024
Blood pharming: exploring the progress and hurdles in producing in-vitro red blood cells for therapeutic applications
Frontiers in Hematology
doi 10.3389/frhem.2024.1373408
- 6,513 views
- 5 citations
Review
Published on 26 Mar 2024
Asymmetric cell division of hematopoietic stem cells: recent advances, emerging concepts, and future perspectives
Frontiers in Hematology
doi 10.3389/frhem.2024.1373554
- 6,680 views
- 10 citations
Case Report
Published on 21 Mar 2024
Case report: Donor lymphocyte infusion and blinatumomab as treatment for acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation
Frontiers in Hematology
doi 10.3389/frhem.2024.1345884
- 1,608 views
Opinion
Published on 18 Mar 2024
The impact of NETosis on hematological malignancies as a promising therapeutic target
Frontiers in Hematology
doi 10.3389/frhem.2024.1377806
- 2,490 views
- 3 citations
Review
Published on 08 Mar 2024
Management of secondary immunodeficiency in hematological malignancies: a Delphi consensus from the Middle East
Frontiers in Hematology
doi 10.3389/frhem.2024.1347708
- 3,779 views
- 3 citations